Emerging infectious diseases · 2021 · 22 citations · 17 references
Public HealthInfectious DiseasesPreventive MedicineAntimicrobial PharmacotherapyDisease PreventionTuberculosis ControlDisease ControlPharmacoepidemiologyTuberculosis CareTuberculosis EpidemiologyTuberculosis Infection ControlTuberculosis PreventionDisease Incidence RateDrug-resistant Tuberculosis EpidemiologyFluoroquinolone-based RegimensHigh-risk Population PrevalenceHiv PrevalenceIncidence RateIncidence Rate RatioTuberculosis Drug Resistance
Medscape, LLC designates this Journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
17
Mercedes C. Becerra, Sasha C. Appleton, Molly F. Franke et al. · The Lancet · 2010 · 144 citations
Public Health, Health Sciences, Antimicrobial Resistance +15
Treatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009–2012
Sapna Bamrah, Richard Brostrom, F. Dorina et al. · The International Journal of Tuberculosis and Lung Disease · 2014 · 114 citations · Full text
Public Health, Infectious Disease Control, Infectious Diseases +17